Survey Confirms: RWD and AI Are Now Mission-Critical Infrastructure for Biotechs
The data and insights highlighted are drawn from the Biotech Playbook for Progress, a comprehensive resource built from a 2025 TriNetX survey of 150 biotech and pharma executives. Biotech has always been a high-wire act: big science balanced on limited resources. But...
External Control Arms: What’s Now, What’s Next, and What Truly Matters to Patients
The recent ISPOR Europe 2025 conference, held under the inspiring theme ‘Powering Value and Access Through Patient-Centered Collaboration,’ featured a dedicated track on patient-centered research that underscored ISPOR’s commitment to embedding patient voices at the...
Unlocking the Power of Real-World Data in Rare Disease Research
I recently had the opportunity to sit down with Danny Levine for an episode of his RARECast podcast to discuss something I’m deeply passionate about: how real-world data (RWD) is transforming the landscape of rare disease research. As someone who has spent my...
Breaking Down the Language Barrier in Real-World Data
Access to real-world data (RWD) is no longer the challenge; our ability to interact with it is. The barrier lies in the friction between researchers and the systems designed to unlock RWD’s potential. Unless we remove that friction, the promise of faster, smarter,...
Unlocking the Future of Clinical Trials: Real-World Data, AI, and the Road to 2050
When we think about the future of clinical research, it’s easy to picture gleaming technology, seamless data flows, and a world where trials are faster, smarter, and more inclusive. But let’s be honest. We’re not there yet. That’s exactly the conversation I had in...
TriNetX LIVE™ Named Best of Show Finalist at SCOPE Europe: Transforming Clinical Trial Site Selection Through Data-Driven Intelligence
The clinical trial industry faces a persistent and costly challenge: poor site selection. With up to 85% of trials failing to meet enrollment targets due in part to suboptimal site identification, the path from promising therapeutic concept to patient access remains...
Artificial Intelligence and Real-World Data: The Duo That’s Reshaping Drug Development
In today’s era of exponential data growth, real-world data (RWD) is abundant, but its value hinges on our ability to interpret it with speed, scale, and precision. That’s where artificial intelligence (AI) comes into play. At TriNetX, we’re seeing firsthand how the...
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE Mass., October 15, 2025 — TriNetX, driven by its vision of a connected world where data and...